CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-30 | Larson Betty D EVP, Chief HR Officer | Grant or award · Stock Option (Right to Buy) | +31,055 | 31,055 | ||
| 2024-04-30 | Smart Dalton SVP Fin. - Global Controller | Grant or award · Restricted Stock Unit | +1,393 | 1,393 | ||
| 2024-04-30 | Smart Dalton SVP Fin. - Global Controller | Grant or award · Stock Option (Right to Buy) | +7,031 | 7,031 | ||
| 2024-04-30 | Guindo Chirfi Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +29,297 | 29,297 | ||
| 2024-04-30 | Downing Cristal N Chief Comm. & Public Afrs Ofcr | Grant or award · Stock Option (Right to Buy) | +15,234 | 15,234 | ||
| 2024-04-30 | Zachary Jennifer EVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +35,156 | 35,156 | ||
| 2024-04-30 | Li Dean Y Executive VP & President, MRL | Grant or award · Stock Option (Right to Buy) | +65,625 | 65,625 | ||
| 2024-04-30 | Oosthuizen Johannes Jacobus President, U.S. Market | Grant or award · Stock Option (Right to Buy) | +20,508 | 20,508 | ||
| 2024-04-30 | Davis Robert M Chairman, CEO & President | Grant or award · Stock Option (Right to Buy) | +181,641 | 181,641 | ||
| 2024-04-30 | Chattopadhyay Sanat Exe V-P & Pres. MMD | Grant or award · Stock Option (Right to Buy) | +38,672 | 38,672 | ||
| 2024-04-30 | Williams David Michael EVP,Chief Info&Digital Officer | Grant or award · Stock Option (Right to Buy) | +16,406 | 16,406 | ||
| 2024-04-30 | Klobuchar Michael A EVP - Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +20,508 | 20,508 | ||
| 2024-04-30 | Litchfield Caroline EVP & CFO | Grant or award · Stock Option (Right to Buy) | +49,805 | 49,805 | ||
| 2024-04-30 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Restricted Stock Unit | +23,216 | 23,216 | ||
| 2024-04-30 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2024-03-28 | WENDELL PETER C Director | Grant or award · Phantom Stock | +227.36 | $131.95 | $30K | 124,752.62 |
| 2024-03-28 | Seidman Christine E Director | Grant or award · Phantom Stock | +61.58 | $131.95 | $8K | 12,920.11 |
| 2024-03-28 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +341.04 | $131.95 | $45K | 93,360.4 |
| 2024-03-28 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +227.36 | $131.95 | $30K | 21,049.66 |
| 2024-02-14 | Litchfield Caroline EVP & CFO | Option exercise | +38,291 | $58.08 | $2.2M | 89,199.19 |
Page 17 of 19 · 376 trades